Page last updated: 2024-08-26

1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid and Bladder Cancer

1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid has been researched along with Bladder Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eto, M; Hirata, A; Inokuchi, J; Koga, H; Masuda, K; Naito, S; Okumura, K; Tatsugami, K; Tsunoda, T; Yokomizo, A1

Other Studies

1 other study(ies) available for 1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid and Bladder Cancer

ArticleYear
Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines.
    Oncogene, 2005, Feb-17, Volume: 24, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Calcium; Calcium Channels; Cell Line, Tumor; Chelating Agents; Cisplatin; Cross-Linking Reagents; Down-Regulation; Drug Resistance, Neoplasm; Egtazic Acid; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Inositol 1,4,5-Trisphosphate Receptors; Oligonucleotide Array Sequence Analysis; Poly(ADP-ribose) Polymerases; Receptors, Cytoplasmic and Nuclear; RNA, Small Interfering; Urinary Bladder Neoplasms

2005